In a strategic effort to accelerate digital transformation within regulated manufacturing, Industrial AI leader Seeq has announced a collaboration with AI builder and technology services provider Cognizant to help life sciences and pharmaceutical organizations transition faster from data gathering to actionable insights. The partnership merges Seeq’s advanced industrial AI and operational analytics platform including its GMP-compliant “Seeq for Pharma” suite and newly launched Operational Efficiency and OEE Industry Solution with Cognizant’s deep technical advisory, deployment, and change management capabilities to standardize performance management across multiple production lines and enterprise sites. Addressing traditional industry bottlenecks caused by fragmented, site-specific reporting, the joint initiative targets key operational use cases such as Continued Process Verification (CPV) and Overall Equipment Effectiveness (OEE) by delivering holistic context into asset, process, and scheduling data.
Also Read: BrainCheck Launches Population Analytics to Advance Proactive Cognitive Care Across Health Systems
Highlight the strategic scope of this venture, “At Seeq, we believe the greatest value comes from empowering subject matter experts to understand their processes more deeply, uncover the insights that matter, and turn insights into faster decisions and actions at enterprise scale,” said Dr. Lisa Graham, CEO of Seeq. “Our collaboration with Cognizant begins in life sciences and pharma, where the need is immediate and the opportunity is clear, and creates a strong foundation to help manufacturers across many industries move faster from industrial AI and analytics to measurable business impact.” Underlining the market necessity for unified operations, “Operational efficiency is a major opportunity in the pharmaceuticals industry, yet too many teams still rely on fragmented reporting and local OEE view,” said Paolo Braiuca, Industry Leader for Pharma and Life Sciences at Seeq. “Together with Cognizant, we can help customers scale a more connected, pharma-ready approach to performance improvement across regulated operations.”
